Results 111 to 120 of about 19,801 (209)

The peripheral CD138+ population but not the CD138 population contains myeloma clonogenic cells in plasma cell leukaemia patients [PDF]

open access: yesBritish Journal of Haematology, 2011
David, Chiron   +7 more
openaire   +2 more sources

CO18 | A novel anti-CD138 antibody AT801 to effectively deliver chitosan NBs for targeting of multiple myeloma and reverting tumor microenvironmental invasiveness

open access: yesHaematologica
Introduction. CD138, also known as Syndecan-1, may be a useful immunotherapeutic target for multiple myeloma (MM) treatment being highly expressed on MM cell surfaces, whereas it is express at low levels in benign cells.
Carmela Tangredi
doaj  

Compartment-Specific CD138 Expression Defines an Aggressive Breast Cancer Phenotype with Distinct Transcriptomic Features. [PDF]

open access: yesCancers (Basel)
Asai K   +7 more
europepmc   +1 more source

CD138 expression in the endometrium associates with endometrial timing and inflammatory status but not microbiota composition. [PDF]

open access: yesHum Reprod
Odendaal J   +21 more
europepmc   +1 more source

A CD138+ tumor-associated macrophage/Siglec-F+ neutrophil feed-forward loop promotes immune evasion in pancreatic cancer. [PDF]

open access: yesJ Clin Invest
Wang C   +13 more
europepmc   +1 more source

A retrospective analysis of chronic endometritis and antibiotic therapy in patients with endometriosis. [PDF]

open access: yesSci Rep
Hager M   +6 more
europepmc   +1 more source

IgA nephropathy-associated breast milk B cell alterations. [PDF]

open access: yesFront Immunol
Zachova K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy